Ovarian Hyperstimulation Syndrome: Prevention, Complications, and Treatment

Author:   Tryfon G Lainas ,  George Lainas
Publisher:   Taylor & Francis Ltd
ISBN:  

9780367551100


Pages:   204
Publication Date:   16 December 2025
Format:   Hardback
Availability:   Not yet available   Availability explained
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Our Price $441.00 Quantity:  
Pre-Order

Share |

Ovarian Hyperstimulation Syndrome: Prevention, Complications, and Treatment


Overview

Full Product Details

Author:   Tryfon G Lainas ,  George Lainas
Publisher:   Taylor & Francis Ltd
Imprint:   CRC Press
Weight:   0.560kg
ISBN:  

9780367551100


ISBN 10:   0367551101
Pages:   204
Publication Date:   16 December 2025
Audience:   Professional and scholarly ,  College/higher education ,  Professional & Vocational ,  Postgraduate, Research & Scholarly
Format:   Hardback
Publisher's Status:   Forthcoming
Availability:   Not yet available   Availability explained
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Table of Contents

1.Introduction – Definition 1.1 ART and OHSS Development (Early - Late OHSS) 1.2 Clinical Manifestations of OHSS 1.3 Epidemiology of OHSS l 1.4 Complications of OHSS Rong Li 2. Pathophysiology of OHSS 2.1 The Role of Corpus Luteum and Vascular Permeability 2.2 Genetic Causes of OHSS 3.1 Classification of OHSS 3.1 Historical Classification Systems 3.2 Modern Classification Systems 4. Prediction of OHSS 4.1 Risk Factors for OHSS 4.2 OHSS Prediction Models 5.Primary Prevention: OHSS Reduction Strategies 5.1 GnRH Antagonist Protocols 5.2 Coasting and hCG Dose Reduction 5.3 Types and Doses of Gonadotrophins & Alternative Strategies 5.4 Embryo and Oocyte Cryopreservation 5.5 Oocyte In Vitro Maturation 6. Secondary Prevention: OHSS Elimination Strategies 6.1 GnRH Agonist Trigger and Freeze-All Strategy 6.2 GnRH Agonist and Low-Dose hCG in Luteal Phase 6.3 Alternative Agents for Final Oocyte Maturation (rLH – Kisspeptin) 7.Tertiary Prevention: Outpatient Management 7.1 Luteal GnRH Antagonist Administration 7.2 Dopamine Agonists 7.3 Glucocorticoid Administration 8. Management of Established OHSS 8.1 Management of Late OHSS 8.2 Criteria for Hospitalization – Inpatient Treatment

Reviews

Author Information

George Lainas MD is a Reproductive Gynecologist at Eugonia Assisted Reproductive Unit, Athens, Greece, and Senior Deputy of the Special Interest Group in Reproductive Endocrinology of the European Society of Human Reproduction and Embryology. Dr Lainas is also a member of the Guideline Development Group of Ovarian Stimulation and also a member of the European Committee for the development of Key Performance Indicators (KPIs) in Ovarian Stimulation.His research work has made a significant contribution in the improvement of treatment protocols and prevention of severe complications in IVF; he is a regularly invited speaker at international scientific conferences and seminars and a reviewer in peer-reviewed scientific journals. Tryfon G Lainas MD, PhD, is Director of the Eugonia Assisted Reproductive Unit, Athens, Greece; the former head of the department of endoscopic surgery at 'IASO' maternity hospital, he also organized the 1st International Seminar of Perinatal Medicine on the biology of reproduction in 1992.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List